Jamieson is pleased to have been able to advise the Alcaliber management team on the sale from Torreal and Sanofi to new owners GHO Capital. Alcaliber is a leading independent supplier of Active Pharmaceuticals Ingredients to the global pharmaceutical industry. The Company is headquartered in Spain and has a 45-year track record of best-in-class industrial operations in a tightly regulated subsector niche with high barriers to entry. Alcaliber and its specialist subsidiary, Linneo Health, are sector leading businesses with state of the art production facilities and a reputation for quality of product resulting in stable, sustainable growth.

The team from Jamieson was led by Jose Basabe, supported by Ross Wheeler and Pippa Knowles

Jamieson is delighted to announce that it has advised Rachael Wyllie and the management team of CRF Health on the acquisition of the business by Genstar Capital from Vitruvian Partners. As part of the transaction, CRF will be combined with Bracket, a Genstar portfolio company. The transaction is expected to complete by the end of 2018 and is subject to customary closing and regulatory approvals.

CRF Health is the leading provider of eSource technology solutions for the life sciences industry. The business has experience in more than 800 clinical trials across 74 countries. The management team has delivered excellent financial growth in recent years.

Rachael Wyllie, CEO of CRF Health and Executive Chairman of the combined group commented: "This is an exciting step forward for patients, clients, and our new combined team. The complementary nature of the two businesses provides us with the platform and scale for future growth in our dynamic markets, while ensuring our customers have more access to the latest patient-centric innovations in clinical research."

The Jamieson team of Ian Jamieson, Stephen Maxwell and Gus Gayford advised the CRF team on the transaction and the management incentive arrangements to be implemented under Genstar’s majority ownership.

Jamieson is delighted to announce that it has advised the management team of Portman Dental Care, led by Sam Waley-Cohen (Founder and CEO), on Core Equity’s acquisition of a majority stake in the business.

Portman was established in 2009 and has grown rapidly, with over 75 dental practices at time of writing. The company focuses on the private dental market in the UK and has a proven track record of growth through the successful acquisition and integration of independent practices.

As part of the transaction, Livingbridge, which first invested in Portman in 2014, will fully exit its investment.

The Jamieson team, led by Stuart Coventry and Gus Gayford, advised Sam Waley-Cohen and the Portman management team on their reinvestment alongside Core Equity and equity incentive arrangements in the new structure.

Jamieson has advised CEO Lynne Hill and CFO Paul Coxon of Linnaeus Group on the acquisition of the business by Mars Petcare from private equity firm Sovereign Capital Partners.

Linnaeus is a leading veterinary services group comprising some of the most highly-respected practices in the UK. The group, which formed in September 2014, has seen continued growth and investment in its service offering. This has enabled Linnaeus to maintain its position at the forefront of specialist and first opinion veterinary services and excellence. Linnaeus employs approximately 1,400 staff, including 370 clinicians and 77 of the leading specialist veterinary surgeons in the world. On completion of the transaction, Linnaeus will become a unit within Mars Petcare’s Veterinary Health Group and Linnaeus’s existing management will continue to lead the business.

Lynne Hill and Paul Coxon were advised by Stuart Coventry, Ross Wheeler and Gus Gayford.

MPT Jamieson advised CEO Sibylle Stauch-Eckmann and the Ober Scharrer Management Team on their equity incentive arrangements in the new structure and their re-investment alongside Nordic Capital.

OSG, is a recognised innovator in the field of ophthalmology, providing state-of-the-art medical care to both public and private patients. The Group specialises in eye surgeries with more than 90,000 surgical procedures performed annually.

Nordic Capital Fund IX acquired OSG in April 2018. The ambition is to support the further development of OSG in line with its current strategy of providing innovative medical care of the highest quality.

The team was advised by Stuart Coventry, Karin Himmelreich and Laura Yell.

Jamieson has advised CEO Norman Smith and the management team of Vision RT on the acquisition of a majority stake in the business by the Danish medtech investment company, William Demant Invest (WDI). WDI is a long-term, evergreen investor with considerable medical device industry experience.

Following almost 17 years since its inception, Vision RT, the leading supplier of Surface Guided Radiation Therapy (SGRT) has transferred the majority of its longstanding privately held shareholding to WDI. Vision RT’s founders, Norman Smith, Gideon Hale and Ivan Meir continue as shareholders and the company will remain in its previous standalone form, with the same strategy, structure and management as before.

The management team were advised by Tom Burton and Ross Wheeler on their investment and the new management incentive plan.

Tom Burton, Ross Wheeler and Pippa Knowles advised the team on the terms of the new management incentive plan.

European private-equity firm Nordic Capital (“Nordic”) has agreed to acquire two dental business from Hesira Group Ltd (“Hesira”), a portfolio company of Oaktree Capital. The businesses being sold are Adent Cliniques Dentaires Group SA (“Adent”, Switzerland) and Top Mondzorg BV (“Dental Clinics”, Netherlands).

At the time of the sale, the two businesses owned over 100 clinics (22 clinics in Switzerland, 88 clinics in the Netherlands). Nordic intends to continue increasing the size and coverage of the group by combining the businesses with two German dental practice operators it has agreed to acquire in a separate transaction.

John Greenland, Laura Yell and Pippa Knowles advised management on their investment in the new structure and assisted in negotiating a competitive equity incentive plan.

Jamieson is pleased to announce that it advised CEO KP Doyle and the management team of Active Assistance, the leading provider of care and support for individuals with complex neurological conditions, on the acquisition by Montreux Capital Management from August Equity for an undisclosed sum.

Active Assistance provides specialist care to individuals with a range of conditions including acquired brain injury, spinal cord injury and other neurological disorders. Active Assistance will offer a new platform from which to consolidate the highly fragmented specialist care sector through the next investment cycle.

The management team of Active Assistance were advised by Stuart Coventry and Ross Wheeler on the terms of the Management Incentive Plan to be implemented as part of the transaction

Curaeos is a vertically integrated dental services provider with activities in the Netherlands, Belgium, Denmark, Germany and Italy. The Company focuses on providing affordable high-quality dental care and is known for brands like DentConnect and DentalCoop. Curaeos provides a full range of both general and specialist dental care products and services. The Company is headquartered in Oosterhout, the Netherlands, and serves over one million patients through its pan-European network of over 220 clinics.

The process was highly competitive and the deal was agreed within a tight time frame.   Jamieson advised the management team on their reinvestment terms alongside EQT and on the structuring of their new incentive arrangements, including addressing the various tax jurisdictions of the managers and ensuring flexibility on terms to benefit from the company’s continued buy and build strategy. 

The transaction represents Jamieson’s 3rd deal in the Netherlands in 2017.  The Jamieson team was led by Stuart Coventry, Ross Wheeler and Gus Gayford